Clinical Trial Update: Post-Implant Performance of the EC-3 IOL

View source ↗

Summary

Clinical trial update on the post-implant performance of the EC-3 intraocular lens in cataract patients. The current trial status is reported as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• EC-3 intraocular lens (intraocular lens)

Snippet

Sponsor: Aaren Scientific Inc. | Conditions: Cataract | Status: UNKNOWN